Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pineapple refers to both the fruit of the plant *Ananas comosus* and various extracts derived from it. In a pharmaceutical context, "pineapple" may refer to allergenic extracts used in allergy testing or dietary supplements containing bromelain, a proteolytic enzyme complex found in the stem and juice of pineapples. Bromelain is promoted for its anti-inflammatory properties and has been approved by regulatory agencies (including the FDA) as a topical agent for debridement of severe burns. Pineapple-derived products have also been traditionally used for digestive issues and inflammation; however, robust clinical evidence supporting most uses is limited. The mechanism of action for bromelain involves proteolytic activity that breaks down proteins and modulates inflammatory processes[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pineapple.